Literature DB >> 30954439

Zfhx3 is essential for progesterone/progesterone receptor signaling to drive ductal side-branching and alveologenesis in mouse mammary glands.

Gui Ma1, Ang Gao1, Yinan Yang1, Yuan He1, Xi Zhang1, Baotong Zhang2, Zhiqian Zhang1, Mei Li3, Xing Fu1, Dan Zhao1, Rui Wu1, Leilei Qi1, Qingxia Hu1, Juan Li1, Liya Fu1, Zhengmao Zhu1, Jin-Tang Dong4.   

Abstract

Progesterone (Pg)/progesterone receptor (PR) signaling drives mammary gland side-branching and alveologenesis, but the mechanisms through which Pg/PR signaling functions remain to be clarified. Using in vitro and in vivo models and histological and molecular analyses, we determined the role of Zfhx3 transcription factor in mammary gland development driven by Pg/PR signaling. Postnatal deletion of Zfhx3 in mouse mammary epithelial cells attenuated side-branching morphogenesis and alveologenesis. These effects were undetectable in the absence of Pg/PR signaling. During the estrus cycle, Zfhx3 expression corresponded to that of Pg, being at the highest level at the diestrus stage; Zfhx3 deletion inhibited mammary gland branching more potently at diestrus than estrus stage. Loss of Zfhx3 not only attenuated the expansion of stem/progenitor cells driven by Pg/PR signaling, but also impaired the function of Pg/PR signaling in the transcriptional activation of multiple genes. In addition, Pg/PR signaling significantly expanded PR- and Zfhx3-positive epithelial cells, and induced the physical association of ZFHX3 with PR. These findings establish Zfhx3 as an integral transcription factor of Pg/PR signaling in driving side-branching and alveologenesis during mammary gland development.
Copyright © 2019 Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alveologenesis; Ductal side-branching; Mammary gland; Pregnancy; Progesterone-progesterone receptor signaling; Zfhx3/Atbf1

Year:  2019        PMID: 30954439     DOI: 10.1016/j.jgg.2019.03.003

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  4 in total

1.  Intratumoral injection of caerin 1.1 and 1.9 peptides increases the efficacy of vaccinated TC-1 tumor-bearing mice with PD-1 blockade by modulating macrophage heterogeneity and the activation of CD8+ T cells in the tumor microenvironment.

Authors:  Guoying Ni; Xiaodan Yang; Junjie Li; Xiaolian Wu; Ying Liu; Hejie Li; Shu Chen; Conor E Fogarty; Ian H Frazer; Guoqiang Chen; Xiaosong Liu; Tianfang Wang
Journal:  Clin Transl Immunology       Date:  2021-08-17

2.  SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.

Authors:  Rui Wu; Jiali Fang; Mingcheng Liu; Jun A; Jinming Liu; Wenxuan Chen; Juan Li; Gui Ma; Zhiqian Zhang; Baotong Zhang; Liya Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2020-04-05       Impact factor: 5.157

3.  ZFHX3 is indispensable for ERβ to inhibit cell proliferation via MYC downregulation in prostate cancer cells.

Authors:  Qingxia Hu; Baotong Zhang; Rui Chen; Changying Fu; Jun A; Xing Fu; Juan Li; Liya Fu; Zhiqian Zhang; Jin-Tang Dong
Journal:  Oncogenesis       Date:  2019-04-12       Impact factor: 7.485

4.  AR imposes different effects on ZFHX3 transcription depending on androgen status in prostate cancer cells.

Authors:  Xing Fu; Zhiqian Zhang; Mingcheng Liu; Juan Li; Jun A; Liya Fu; Chenyang Huang; Jin-Tang Dong
Journal:  J Cell Mol Med       Date:  2021-12-24       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.